Because of their glucose lowering effects, therapies that enhance incretin actions through inhibiting degradation of endogenous incretins or through activation of the GLP-1 receptor are now in use for the treatment of type 2 diabetes (21, 22)
Looking ahead, Mounjaro (tirzepatide) and Zepbound (tirzepatide) are expected to lead with rapid expansion, which is attributed to enhanced efficacy resulting from their dual mechanism of action on both GLP-1 and GIP receptors, leading them toward notable market advancement
To view or add a comment, sign in Is Triple GLP the Future of Obesity Treatment
It stimulates the pancreas to start releasing insulin once meals are consumed
1, 2, 3, 4 This has motivated research into lifestyle interventions and drugs for prevention and treatment of these diseases
The peptide incorporates specific amino acid substitutions that make it resistant to dipeptidyl peptidase-4 (DPP-4), the enzyme primarily responsible for degrading natural GHRH